Clinical approach to the management of intestinal failure associated liver disease (ifald) in adults: a position paper from the home artificial nutrition and chronic intestinal failure special interest group of ESPEN

We recommend that intestinal failure associated liver disease (IFALD) should be diagnosed by the presence of abnormal liver function tests and/or evidence of radiological and/or histological liver abnormalities occurring in an individual with IF, in the absence of another primary parenchymal liver pathology (e.g. viral or autoimmune hepatitis), other hepatotoxic factors (e.g. alcohol/medication) or biliary obstruction. The presence or absence of sepsis should be noted, along with the duration of PN administration.

Source: Clinical Nutrition - July 9, 2018 Category: Nutrition Authors: Simon Lal, Loris Pironi, Geert Wanten, Jann Arends, Federico Bozzetti, Cristina Cuerda, Francisca Joly, Darlene Kelly, Michael Staun, Kinga Szczepanek, Andre Van Gossum, Stephane Michel Schneider, the Home Artificial Nutrition & Chronic Intestinal Failur Tags: ESPEN Endorsed Recommendation Source Type: research